MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,642,000 | +49.8% | 47,309 | +58.9% | 0.52% | +32.2% |
| Q1 2021 | $5,101,000 | -22.0% | 29,779 | 0.0% | 0.39% | -32.7% |
| Q4 2020 | $6,541,000 | +19.4% | 29,779 | -9.8% | 0.58% | +8.0% |
| Q3 2020 | $5,480,000 | -33.3% | 33,000 | -54.2% | 0.54% | -30.4% |
| Q2 2020 | $8,220,000 | +54.6% | 72,000 | -36.2% | 0.77% | +26.5% |
| Q3 2018 | $5,318,000 | +652.2% | 112,908 | +687.6% | 0.61% | +529.9% |
| Q2 2018 | $707,000 | +84.6% | 14,335 | -82.2% | 0.10% | 0.0% |
| Q4 2016 | $383,000 | -61.4% | 80,528 | -46.3% | 0.10% | -40.1% |
| Q3 2016 | $992,000 | +21.1% | 150,000 | 0.0% | 0.16% | -23.9% |
| Q2 2016 | $819,000 | -70.3% | 150,000 | +87.5% | 0.21% | -39.3% |
| Q3 2015 | $2,754,000 | -7.9% | 80,000 | -15.8% | 0.35% | +19.8% |
| Q2 2015 | $2,990,000 | +2.0% | 95,000 | -5.0% | 0.29% | -3.9% |
| Q1 2015 | $2,932,000 | – | 100,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |